Pages that link to "Q48704602"

The following pages link to Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice. (Q48704602):

Displaying 11 items.

• Obesity: Current and potential pharmacotherapeutics and targets (Q30243992) (← links)
• Chemical-shift water-fat MRI of white adipose depots: inability to resolve cell size differences (Q30625145) (← links)
• Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (Q33718134) (← links)
• Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models (Q34286437) (← links)
• New insights on the role of the endocannabinoid system in the regulation of energy balance. (Q34494301) (← links)
• The endocannabinoid/endovanilloid system and depression (Q34567576) (← links)
• Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity (Q38057717) (← links)
• Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity. (Q38099388) (← links)
• New perspectives on the development of antiobesity drugs (Q38397340) (← links)
• Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice. (Q42823729) (← links)
• Novel analgesic effects of melanin-concentrating hormone on persistent neuropathic and inflammatory pain in mice (Q49663721) (← links)